Trial Profile
Multiple ascending subcutaneous (SC) dose study of MEDI-563: Pharmacokinetics and immune response in adult asthmatics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors MedImmune
- 10 Jan 2011 Status changed from not stated to completed.
- 10 Jan 2011 New trial record